---
DrugClass: "[[Pituitary and Adrenocortical Hormones]]"
SubClass: "[[Anterior pituitary hormones]]"
DrugClassAdverse: "[[Gonadotropins Follicle-Stimulating Hormone and Luteinizing Hormone#Adverse Reactions]]"
DrugClassContra: "[[Gonadotropins Follicle-Stimulating Hormone and Luteinizing Hormone#Contraindications]]"
BrandName: Orilissa
SecondaryDrugClass: 
SecondarySubClass: 
SecondaryAdverse: 
SecondaryContra: 
ThirdDrugClass: 
ThirdSubClass: 
ThirdAdverse: 
ThirdContra: 
FourthDrugClass: 
FourthSubClass: 
FourthAdverse: 
FourthContra: 
Chapter: "41"
KindleLinkChap: "[Chapter 41](kindle://book?action=open&asin=B09FRF11YJ&location=23770)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
aliases: 
SubCat: Gonadotropin-Releasing Hormones/ Synthetics
---
```smiles
CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)C[C@@H](C3=CC=CC=C3)NCCCC(=O)O)C4=C(C(=CC=C4)OC)F
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
[[Endometriosis]]
150â€“ 200 mg orally daily

### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action


### Side/Adverse Effects
See `= this.DrugClassAdverse`
Hot flashes, night sweats, headache, decreased bone density

### Interactions

`= this.ChemLink+this.file.name`

